Akebia Therapeutics (AKBA) EBIT (2013 - 2026)
Akebia Therapeutics (AKBA) posted quarterly EBIT of -$4.7 million for Q1 2026, down 134.75% year-over-year from $13.5 million in Q1 2025, and up 45.1% quarter-over-quarter from -$8.6 million in Q4 2025.
Akebia Therapeutics (AKBA) EBIT (2013 - 2026) Analysis & Trends
Akebia Therapeutics (AKBA) has reported EBIT for 14 consecutive years, with -$4.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, EBIT fell 134.75% year-over-year to -$4.7 million; the TTM figure through Mar 2026 stood at $5.3 million (up 124.02% YoY), while the FY2025 annual figure was $23.5 million, up 146.56% from the prior year.
- EBIT grew to -$4.7 million in Q1 2026 per AKBA's latest filing, from -$8.6 million in the prior quarter.
- Across five years, EBIT topped out at $34.1 million in Q2 2022 and bottomed at -$59.6 million in Q1 2022.
- Historically, EBIT has averaged -$9.3 million across 5 years, with a median of -$8.7 million in 2024.
- Annual changes were most pronounced in 2024 — EBIT plunged 1141.27% — and 2025, when it jumped 261.48%.
- Akebia Therapeutics' EBIT stood at -$4.9 million in 2022, then jumped by 128.22% to $1.4 million in 2023, then slumped by 1141.27% to -$14.3 million in 2024, then jumped by 40.22% to -$8.6 million in 2025, then surged by 45.1% to -$4.7 million in 2026.
- Business Quant data shows AKBA's EBIT at -$4.7 million in Q1 2026, -$8.6 million in Q4 2025, and $4.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Akebia Therapeutics | 249.25 Mn | 93.70 Mn | 38.70 Mn | -6.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.33 Mn |
| Mar 31, 2026 | -4.70 Mn |
| Dec 31, 2025 | -8.55 Mn |
| Sep 30, 2025 | 4.45 Mn |
| Jun 30, 2025 | 14.09 Mn |
| Mar 31, 2025 | 13.51 Mn |
| Dec 31, 2024 | -14.31 Mn |
| Sep 30, 2024 | -12.51 Mn |
| Jun 30, 2024 | -8.73 Mn |
| Mar 31, 2024 | -14.94 Mn |
| Dec 31, 2023 | 1.37 Mn |
| Sep 30, 2023 | -13.04 Mn |
| Jun 30, 2023 | -9.00 Mn |
| Mar 31, 2023 | -25.60 Mn |
| Dec 31, 2022 | -4.87 Mn |
| Sep 30, 2022 | -50.41 Mn |
| Jun 30, 2022 | 34.08 Mn |
| Mar 31, 2022 | -59.58 Mn |
| Dec 31, 2021 | -65.34 Mn |
| Sep 30, 2021 | -54.89 Mn |